CASE Op-Ed – InsideSources: Government Mandates Are Wrong Solution to Surprise Medical Bills
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
Gerard Scimeca – Chairman, CASE October 8, 2019 There is an impulse among some lawmakers that whatever the problem, more...
As Congress continues to debate the best fixes for our healthcare system, our representatives in Washington have an opportunity to...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/